Ketamine for Refractory Chronic Migraine: a Pilot Study
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
Ketamine is a drug used for anesthesia but at low doses it is a very effective pain reliever
in several chronic conditions. Preliminary studies have shown that ketamine might be
effective for patients with refractory chronic migraine, which is a severe type of headache
for which patients usually have tried and failed many medications and can cause severe
disability to their lives. This study will evaluate ketamine prospectively when given to
patients who have "failed" an initial inpatient treatment.